NCT07293156

Brief Summary

Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes. In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2026

Completed
Last Updated

June 25, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 8, 2025

Last Update Submit

June 23, 2026

Conditions

Keywords

Diabete MellitusErectile dysfunctionPilates exercisesPelvic floor exercises

Outcome Measures

Primary Outcomes (1)

  • penile perfusion

    Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV)

    Base line and after 12 weeks

Secondary Outcomes (1)

  • International Index of Erectile Function-5 (IIEF-5) scale.

    Baseline and after 12 weeks

Study Arms (2)

Experimental

EXPERIMENTAL
Other: Pilate ExercisesOther: Home based pelvic floor muscle trainingDrug: Sildenafil therapy

Active comparator

ACTIVE COMPARATOR
Other: Home based pelvic floor muscle trainingDrug: Sildenafil therapy

Interventions

Participants will receive sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.

Active comparatorExperimental

Participants will attend an educational session conducted by a physiotherapist on pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They will be instructed on proper pelvic floor muscle contraction by simulating the interruption of urine flow and performing maximal voluntary contractions. A home-based PFMT program will be prescribed. Exercises will initially be performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants will be instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence will be monitored through a mobile messaging application, where participants will report completion of daily exercises and receive reminders when necessary.

Active comparatorExperimental

Pilates protocol that will be used in the present study consisted of 11 different Pilates postures: Pilates Breathing, Spine Stretch, Swan, Shoulder Bridge, Hundreds, Double Leg Stretch, Footwork, Roll up, Single Leg Stretch, Leg Pull Back, Kick front and back. It will be performed thrice a week, with each session lasting 60 minutes, for 12 weeks, totaling 36 sessions. The progression of the exercises will be based on increasing the number of repetitions of the exercise, and variations in posture from beginner to intermediate and advanced, for each exercise. The movements will be repeated six to eight times each.

Experimental

Eligibility Criteria

Age40 Years - 60 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMales with diabetic erectile dysfunction
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Men aged 40-60 years.
  • Married.
  • Diagnosed with type 2 diabetes mellitus for \>5 years, with initial diagnosis confirmed by HbA1c \>6.5%.
  • Arteriogenic erectile dysfunction (ED) of \>6 months' duration, confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries \<25 cm/s.
  • Body mass index (BMI) \<30 kg/m².

You may not qualify if:

  • Poorly controlled diabetes mellitus (HbA1c \>9%).
  • Neurogenic, venogenic, or psychogenic ED.
  • Cardiac conditions contraindicating sexual activity.
  • Neurological disorders or spinal cord injury.
  • Alcohol abuse or illicit drug use.
  • Chronic hematological disorders.
  • Active genitourinary infection.
  • Severe hypogonadism.
  • History of radical prostatectomy, pelvic surgery, or pelvic trauma.
  • Penile prosthesis implantation.
  • Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient clinic, faculty of Physical Therapy, Benha university

Banhā, Benha, Egypt

Location

MeSH Terms

Conditions

Diabetes MellitusErectile Dysfunction

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes Assessor blinded This is a parallel group randomized controlled trial with two arms receiving different interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventional
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical Therapy

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 19, 2025

Study Start

December 15, 2025

Primary Completion

June 22, 2026

Study Completion

June 23, 2026

Last Updated

June 25, 2026

Record last verified: 2025-12

Locations